Search clinical trials for: Syndecan 2

Total 47964 results

Centre Hospitalier Universitaire de Besancon

Active, not recruiting

Medium and Long Term Follow-up of COVID-19 Infected Patients: Research and Characterization of Pulmonary Sequelae (COV-RECUP)

Sars-CoV2

France
Institut National de la Santé Et de la Recherche...

Completed

Health, Perception, Practices, Relations and Social Inequalities in the General Population During the Covid-19 Crisis (SAPRIS-SERO)

SARS-CoV 2

France
ModernaTX, Inc.

Completed

A Study to Evaluate the Immunogenicity and Safety of mRNA Vaccine Boosters for SARS-CoV-2 (COVID-19) Variants

SARS-CoV-2

United States
Instituto Nacional de Cancerologia de Mexico
Roche Pharma AG

Active, not recruiting

Tocilizumab Treatment in Patients With COVID-19

Sars-CoV2

Mexico
Ology Bioservices
Enabling Biotechnologies (EB)

Completed

Study of Monoclonal Antibody Cocktail Being Tested for the Prevention of COVID-19

SARS-CoV-2

United States
ModernaTX, Inc.

Terminated

Moderna COVID-19 Vaccine mRNA-1273 Observational Pregnancy Outcome Study

SARS-CoV-2

United States
Direction Centrale du Service de Santé des Armées

Completed

SARS-CoV2 (COVID-19) Diagnosis in Human Saliva by MALDI-TOF MS Profiling (CoviDiagMS)

SARS-CoV 2

France
ModernaTX, Inc.

Completed

A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1283 and mRNA-1273 Vaccines in Healthy Adults Between 18 Years and 55 Years of Age to Prevent COVID-19

SARS-CoV-2

United States
IRCCS San Raffaele Roma

Completed

COVID-19 Epidemiological Surveillance on Healthcare Workers and Patients in a Rehabilitation Medicine Facility (COVID-19)

SARS-Cov2

Italy
Johns Hopkins University
National Institute of Allergy and Infectious Diseases (NIAID); United States... and other collaborators

Completed

Convalescent Plasma to Limit SARS-CoV-2 Associated Complications (CSSC-004)

SARS-CoV 2

United States
ModernaTX, Inc.
Biomedical Advanced Research and Development Authority

Completed

Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older

SARS-CoV-2

United States
Fondazione Epatocentro Ticino

Active, not recruiting

Methylene Blue Treatment of COVID-19

SARS-CoV2

Switzerland
Assistance Publique - Hôpitaux de Paris

Completed

Study of Seroprevalence of Anti-SARS-CoV2 Among Children of Hospital Workers in AP-HP (FamilyPEDCOVID)

SARS-CoV2

France
Centre Hospitalier Universitaire de Besancon

Completed

Study of Viral Load and Maternal-fetal Serology in the Interpretation of the Vertical Transmission of SARS Cov-2 (COVID-19) During Pregnancy (TRANSCOVID)

Sars-CoV2

France
Direction Centrale du Service de Santé des Armées

Completed

Study of SARS-CoV2 Virus (COVID-19) Seroprevalence in the Population of Creil Air Force Base (BA110) (EpiCovCreil)

Sars-CoV2

France
Centre Hospitalier Universitaire Vaudois

Completed

Dry Versus Wet Nasopharyngeal Rapid Test for the Detection of COVID-19. (RESTART)

SARS-CoV-2

Switzerland
Direction Centrale du Service de Santé des Armées

Completed

Study of the SARS-COV-2 (COVID-19) Serological Profile of an Army Training Hospital Staff (SEROSARSCOV)

Sars-CoV2

France
Latin American Cooperative Oncology Group
Oncoclínicas

Withdrawn

HOPE: A Trial of Hydroxichloroquine Plus Azithromycin in High Risk COVID-19 (HOPE_BRAZIL)

Sars-CoV2

Brazil
Morphic Therapeutic, Inc

Recruiting

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease (GARNET)

Inflammatory Bowel Diseases | Crohn's Disease

United States, Poland, Georgia, Slovakia, Romania, Croatia, Germany, Spain
Hebei Senlang Biotechnology Inc., Ltd.

Recruiting

Adult B-ALL Treated by CART Cell Bridging Allogeneic Hematopoietic Stem Cell Transplantation

Adult B Acute Lymphoblastic Leukemia

China
Array Biopharma, now a wholly owned subsidiary...

Withdrawn

Efficacy and Safety of LGX818 in Patients With Advanced or Metastatic BRAF V600 Mutant NSCLC

Non-Small Cell Lung Cancer

United States
Sucampo Pharma Americas, LLC
Sucampo AG; Sucampo Pharmaceuticals, Inc.

Completed

Evaluation of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to Placebo

Chronic Idiopathic Constipation

United States
Université Catholique de Louvain
Northern State Medical University

Completed

A RESearch on the PrEvalence and the Diagnosis of COPD and Its Tobacco-related Etiology (RESPECT)

Chronic Obstructive Pulmonary Disease

Russian Federation
Dinora, Inc.
PharPoint Research, Inc.; Analgesic Solutions

Terminated

Delayed Release Prednisone in PMR

Polymyalgia Rheumatica

United States
Hebei Senlang Biotechnology Inc., Ltd.
The Second Hospital of Hebei Medical University

Unknown

CAR T Cells for Refractory B Cell Malignancy

B-Cell Leukemia | B-Cell Lymphoma

China
Nestlé

Completed

Pre/Term Milk Profiling

Preterm Milk | Term Milk

Switzerland
VANBIERVLIET

Completed

Comparison of Two Needles (ProCore vs EchoTip) for the Diagnosis of Pancreatic Solid Mass Under EUS (PICORE)

Pancreatic Tumor | Endoscopic Ultrasonography | Fine Needle Aspiration

France
Kyorin University

Completed

MicroRNA Expression in Human Blood Serum and Vitreous Body

MicroRNA Expression Profile in Human Vitreous

Japan
The Danish Research Centre for Chemical Sensitivities

Completed

Mindfulness-based Cognitive Therapy for Individuals With Multiple Chemical Sensitivity

Multiple Chemical Sensitivity

Denmark
China Medical University Hospital

Unknown

The Relationship Between Single Nucleotide Polymorphisms of Chitinase 3-like 1 Gene,YKL-40 Serum Levels and Adult Asthma (CHI3L1)

Asthma

Taiwan
Gilead Sciences

Completed

An Open-Label Study of Emtricitabine in Combination With Other Antiretroviral Agents in HIV Infected Pediatric Subjects

HIV Infections

Romania
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Cadonilimab Plus Chemotherapy as First-line Treatment for PD-L1 Negative NSCLC (LungCadX)

NSCLC

China
Johannes Gutenberg University Mainz

Recruiting

Mainz Intracoronary Database. The Coronary Slow-flow and Microvascular Diseases Registry (MICAT)

Coronary Artery Disease | Microvascular Dysfunction

Germany
Novartis Pharmaceuticals

Completed

Effect of the Fixed Dose Combination Amlodipine/Valsartan on Central Aortic Blood Pressure in Uncontrolled Essential Hypertension With Amlodipine 5 mg (EXPLOR)

Hypertension

France
Gerencia De Atencion Primaria Area 2 De Madrid
Health Research Fund of ISCIII Spain

Completed

Development, Implementation and Evaluation of the Impact of a Guideline in Clinical Practise for Cardiovascular Risk

Cardiovascular Risk Factors | Primary Care | Clinical Practice Guideline | Implementation Strategies

Spain
Memorial Sloan Kettering Cancer Center
National Institutes of Health (NIH)

Recruiting

Testing a New Imaging Agent to Identify Cancer

HER2-positive Metastatic Breast Cancer | HER-2 Protein Overexpression | HER-2 Positive Malignant Carcinoma of Breast

United States
University of Kansas Medical Center
National Institute on Aging (NIA)

Completed

Dementia Risk and Dynamic Response to Exercise (DYNAMIC)

Healthy Aging | Alzheimer Disease 2 Due to Apoe4 Isoform

United States
Pfizer

Completed

Follow-up Study on the Antibody Response to Hepatitis B, Acellular Pertussis Toxin and Inactivated Poliovirus Antigens 1 Month After the 4th Hexavac® Vaccination in Healthy Children, Who Participated in NeisVac-C Study 216

Meningococcal Meninigitis, Serogroup C

Austria, Germany
Sichuan Academy of Medical Sciences

Recruiting

Dapagliflozin Delays the Loss of Renal Function in Peritoneal Dialysis Patients

Peritoneal Dialysis Complication | Renal Function Aggravated | Sodium-glucose Co-transporter-2 Inhibitors

China
AIM Vaccine Co., Ltd.
Ningbo Rongan Biological Pharmaceutical Co. Ltd.; LiveRNA Therapeutics Inc.; AIM...

Recruiting

A Global Multi-center Clinical Study of SARS-CoV-2 mRNA Vaccine for the Prevention of COVID-19

SARS-CoV-2

Kenya
ModernaTX, Inc.

Recruiting

A Study to Evaluate the Safety and Immunogenicity of the mRNA COVID-19 Vaccines in Healthy Children Between 6 Months to Less Than 6 Years of Age

SARS-CoV-2

United States, Puerto Rico, Panama
University of Pennsylvania

Not yet recruiting

ACE2 Chewing Gum on SARS-CoV-2 Viral Load (COVID 19)

SARS-CoV-2

United States
University Hospital, Lille

Recruiting

Rapid Detection of COVID-19 by Portable and Connected Biosensor (COR-DIAL-1)

Sars-CoV2

France
AstraZeneca

Completed

AZD7442 Pharmacokinetics, Pharmacodynamics, and Safety Evaluation in Pediatrics (TRUST)

SARS-CoV-2

United States, Belgium, United Kingdom, Brazil, Germany
Centre Hospitalier Saint Joseph Saint Luc de Lyon

Completed

Serological Study of the Exposure of Personnel to COVID-19 (SEROPHUGAC)

Sars-CoV2

France
ModernaTX, Inc.
Aetion, Inc.

Active, not recruiting

Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran

SARS-CoV-2

United States
Entos Pharmaceuticals Inc.
Canadian Institutes of Health Research (CIHR); Aegis Life, Inc.; Clinical Pharma... and other collaborators

Completed

A Clinical Trial of a Prophylactic Plasmid DNA Vaccine for COVID-19 [Covigenix VAX-001] in Adults

SARS-CoV-2

Burkina Faso, Canada, Senegal, South Africa
Yale University

Completed

Colchicine/Statins for the Prevention of COVID-19 Complications (COLSTAT) Trial (COLSTAT)

SARS-CoV-2

United States
AIM Vaccine Co., Ltd.
First Affiliated Hospital Bengbu Medical College; Ningbo Rongan Biological...

Active, not recruiting

A Preliminary Exploratory Cohort Study of COVID-19 mRNA Vaccine, Bivalent in Participants Aged 18 Years and Over in China

SARS-CoV-2

China
Convergent Genomics, Inc.

Completed

Comparison of EPM-IX to Currently Used Specimen Transportation and Extraction Devices ( CGI-EPM-IX ) (CGI-EPM-IX)

SARS-CoV-2

United States

Search clinical trials for: Syndecan 2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Greece

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations